Editor's Note
The Food and Drug Administration (FDA) on February 28 issued a Safety Communication on the safety and effectiveness of using robotically-assisted surgical devices in mastectomy procedures or in the prevention or treatment of cancer in women.
The FDA cited limited, preliminary evidence that the use of robotically-assisted surgical devices for treatment or prevention of cancers that primarily (breast) or exclusively (cervical) affect women may be linked to diminished long-term survival.
Remote surgery has come a long way since the first-ever…
Why reflect on the past? Reflection anchors strategy and revitalizes…
The poster presentations at the 2024 OR Manager Conference showcased…